Skip to main content
Top
Published in: Strahlentherapie und Onkologie 11/2018

01-11-2018 | Original Article

Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer

Authors: Chai Hong Rim, MD, Sangjoon Park, MD, Joong Yeol Woo, CMD, Jinsil Seong, MD, PhD

Published in: Strahlentherapie und Onkologie | Issue 11/2018

Login to get access

Abstract

Purpose

We investigated whether external beam radiotherapy (EBRT) could induce compensatory liver hypertrophy in liver cancers and assessed related clinical factors.

Methods

A total of 82 consecutive patients receiving EBRT for hepatocellular carcinoma (n = 77) or cholangiocarcinoma (n = 5) from April 2012 to June 2014 were recruited and divided into two subgroups according to tumor location in the right or left lobe. The left lateral and right lobes were considered as unirradiated volumes accordingly. Total liver volume (TLV), nontumor liver volume (NLV), left and right lobe whole volume (LLWV and RLWV, respectively), volume of liver irradiated < 30 Gy (V<30Gy), Child–Pugh (CPS) score, future liver remnant (FLR) ratio, and percentage of FLR hypertrophy from baseline (%FLR) were assessed.

Results

In the right lobe group, %FLR hypertrophy and LLWV increased significantly at all follow-ups (p < 0.001). %FLR hypertrophy steadily increased until the fourth follow-up. Multivariate analysis showed that the factor associated with maximum %FLR hypertrophy was tumor extent (upper or lower lobe vs. both lobes; p = 0.022). Post-RT treatments including transarterial chemoembolization or hepatic arterial infusion chemotherapy were associated with a CPS increase ≥ 2 (p = 0.002). Analysis of the RT only subgroup also showed a significant increase of %FLR until the fourth follow-up (p < 0.001). In the left lobe group, %FLR hypertrophy and RLWV showed no significant changes during follow-up.

Conclusion

Significant compensatory hypertrophy of the liver was observed, with a steady increase of %FLR hypertrophy until the fourth follow-up (median: 396 days). Locally advanced tumors extending across the upper and lower right lobe were a significant factor for compensating hypertrophy after EBRT.
Appendix
Available only for authorised users
Literature
2.
go back to reference Klein J, Dawson LA (2013) Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 87(1):22–32CrossRef Klein J, Dawson LA (2013) Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 87(1):22–32CrossRef
3.
go back to reference Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 22(1):7–17CrossRef Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 22(1):7–17CrossRef
4.
go back to reference Lee HS, Choi GH, Choi JS, Kim KS, Han KH, Seong J et al (2014) Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy. Ann Surg Oncol 21(11):3646–3653CrossRef Lee HS, Choi GH, Choi JS, Kim KS, Han KH, Seong J et al (2014) Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy. Ann Surg Oncol 21(11):3646–3653CrossRef
5.
go back to reference Kubo S, Shiomi S, Tanaka H, Shuto T, Takemura S, Mikami S et al (2002) Evaluation of the effect of portal vein embolization on liver function by 99mTc-galactosyl human serum albumin scintigraphy. J Surg Res 107(1):113–118CrossRef Kubo S, Shiomi S, Tanaka H, Shuto T, Takemura S, Mikami S et al (2002) Evaluation of the effect of portal vein embolization on liver function by 99mTc-galactosyl human serum albumin scintigraphy. J Surg Res 107(1):113–118CrossRef
6.
go back to reference Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC (1993) Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology 17(5):814–819PubMed Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC (1993) Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology 17(5):814–819PubMed
7.
go back to reference Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57CrossRef Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57CrossRef
8.
go back to reference Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A et al (2015) A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery 157(4):690–698CrossRef Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A et al (2015) A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery 157(4):690–698CrossRef
9.
go back to reference Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, Regge D et al (2008) Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 143(10):978–982CrossRef Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, Regge D et al (2008) Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 143(10):978–982CrossRef
10.
go back to reference Zhang G‑Q, Zhang Z‑W, Lau W‑Y, Chen X‑P (2014) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery. Int J Surg 12(5):437–441CrossRef Zhang G‑Q, Zhang Z‑W, Lau W‑Y, Chen X‑P (2014) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery. Int J Surg 12(5):437–441CrossRef
11.
go back to reference Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK et al (2013) Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol 59(5):1029–1036CrossRef Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK et al (2013) Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol 59(5):1029–1036CrossRef
12.
go back to reference Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF et al (2009) Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16(6):1587–1596CrossRef Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF et al (2009) Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16(6):1587–1596CrossRef
13.
go back to reference Tokuuye K, Sumi M, Kagami Y, Murayama S, Kawashima M, Ikeda H et al (2000) Radiotherapy for hepatocellular carcinoma. Strahlenther Onkol 176(9):406–410CrossRef Tokuuye K, Sumi M, Kagami Y, Murayama S, Kawashima M, Ikeda H et al (2000) Radiotherapy for hepatocellular carcinoma. Strahlenther Onkol 176(9):406–410CrossRef
14.
go back to reference Korean Liver Cancer Study Group, National Cancer Center (2015) 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 16(3):465–522CrossRef Korean Liver Cancer Study Group, National Cancer Center (2015) 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 16(3):465–522CrossRef
15.
go back to reference Rim CH, Seong J (2016) Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines. Radiat Oncol J 34(3):160–167CrossRef Rim CH, Seong J (2016) Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines. Radiat Oncol J 34(3):160–167CrossRef
16.
go back to reference Park HC, Yu JI, Cheng JCH, Zeng ZC, Hong JH, Wang MLC et al (2016) Consensus for radiotherapy in hepatocellular carcinoma from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): current practice and future clinical trials. Liver Cancer 5(3):162–174CrossRef Park HC, Yu JI, Cheng JCH, Zeng ZC, Hong JH, Wang MLC et al (2016) Consensus for radiotherapy in hepatocellular carcinoma from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): current practice and future clinical trials. Liver Cancer 5(3):162–174CrossRef
17.
go back to reference Kim TH, Kim DY, Park JW, Kim SH, Choi JI, Kim HB et al (2007) Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67(1):225–231CrossRef Kim TH, Kim DY, Park JW, Kim SH, Choi JI, Kim HB et al (2007) Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67(1):225–231CrossRef
18.
go back to reference Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60CrossRef Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60CrossRef
19.
go back to reference Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A et al (2013) Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume. J Am Coll Surg 217(1):126–133 (Including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach)CrossRef Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A et al (2013) Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume. J Am Coll Surg 217(1):126–133 (Including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach)CrossRef
20.
go back to reference Zhang GQ, Zhang ZW, Lau WY, Chen XP (2014) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery. Int J Surg 12(5):437–441CrossRef Zhang GQ, Zhang ZW, Lau WY, Chen XP (2014) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery. Int J Surg 12(5):437–441CrossRef
21.
go back to reference Imada H, Kato H, Yasuda S, Yamada S, Yanagi T, Hara R et al (2010) Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy—relation to prognosis and liver function. Radiother Oncol 96(2):236–242CrossRef Imada H, Kato H, Yasuda S, Yamada S, Yanagi T, Hara R et al (2010) Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy—relation to prognosis and liver function. Radiother Oncol 96(2):236–242CrossRef
22.
go back to reference May BJ, Madoff DC (2012) Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol 29(2):81–89CrossRef May BJ, Madoff DC (2012) Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol 29(2):81–89CrossRef
23.
go back to reference Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN (2004) Total and segmental liver volume variations: implications for liver surgery. Surgery 135(4):404–410CrossRef Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN (2004) Total and segmental liver volume variations: implications for liver surgery. Surgery 135(4):404–410CrossRef
24.
go back to reference Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE (2008) Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 25(2):92–103CrossRef Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE (2008) Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 25(2):92–103CrossRef
25.
go back to reference de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A et al (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17(8):2081–2089CrossRef de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A et al (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17(8):2081–2089CrossRef
26.
go back to reference Nagino M, Ando M, Kamiya J, Uesaka K, Sano T, Nimura Y (2001) Liver regeneration after major hepatectomy for biliary cancer. Br J Surg 88(8):1084–1091CrossRef Nagino M, Ando M, Kamiya J, Uesaka K, Sano T, Nimura Y (2001) Liver regeneration after major hepatectomy for biliary cancer. Br J Surg 88(8):1084–1091CrossRef
27.
go back to reference Tani M, Tomiya T, Yamada S, Hayashi S, Yahata K, Tamura Y et al (1994) Regulating factors of liver regeneration after hepatectomy. Cancer Chemother Pharmacol 33:S29–S32CrossRef Tani M, Tomiya T, Yamada S, Hayashi S, Yahata K, Tamura Y et al (1994) Regulating factors of liver regeneration after hepatectomy. Cancer Chemother Pharmacol 33:S29–S32CrossRef
28.
go back to reference Denecke T, Seehofer D, Steffen IG, Grieser C, Stelter L, Schnapauff D et al (2011) Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study. J Vasc Interv Radiol 22(9):1254–1262CrossRef Denecke T, Seehofer D, Steffen IG, Grieser C, Stelter L, Schnapauff D et al (2011) Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study. J Vasc Interv Radiol 22(9):1254–1262CrossRef
29.
go back to reference Vogl TJ, Balzer JO, Dette K, Hintze R, Pegios W, Maurer J et al (1998) Initially unresectable hilar cholangiocarcinoma: Hepatic regeneration after transarterial embolization. Radiology 208(1):217–222CrossRef Vogl TJ, Balzer JO, Dette K, Hintze R, Pegios W, Maurer J et al (1998) Initially unresectable hilar cholangiocarcinoma: Hepatic regeneration after transarterial embolization. Radiology 208(1):217–222CrossRef
30.
go back to reference Yamakado K, Takeda K, Matsumura K, Nakatsuka A, Hirano T, Kato N et al (1997) Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol 27(5):871–880CrossRef Yamakado K, Takeda K, Matsumura K, Nakatsuka A, Hirano T, Kato N et al (1997) Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol 27(5):871–880CrossRef
31.
go back to reference Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y et al (2004) Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 139(7):766–774CrossRef Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y et al (2004) Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 139(7):766–774CrossRef
32.
go back to reference Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93(9):1091–1098CrossRef Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93(9):1091–1098CrossRef
Metadata
Title
Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer
Authors
Chai Hong Rim, MD
Sangjoon Park, MD
Joong Yeol Woo, CMD
Jinsil Seong, MD, PhD
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 11/2018
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1342-y

Other articles of this Issue 11/2018

Strahlentherapie und Onkologie 11/2018 Go to the issue